Athelas Company
Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.
Investors
.png)
.jpeg)
.png)
.png)
.png)
.jpeg)
.jpeg)
.png)
Technology:
Biotechnology, Health Care, Life Science
Industry:
Early Drug Development
Headquarters:
Mountain View, California, United States
Founded Date:
2016-06-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
13
Total Funding:
90700000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-08-10
Last Funding Type:
Series B
Register and Claim Ownership